Definitive Healthcare will report Q4 and full-year 2025 financial results on February 26, 2026, with a conference call afterward.
Quiver AI Summary
Definitive Healthcare Corp. will announce its financial results for the fourth quarter and full year ending December 31, 2025, on February 26, 2026, after market close. The company will host a conference call and webcast at 5:00 PM ET to discuss these results, with a live audio stream available on their Investor Relations website and dial-in options for participants. A replay of the call will be accessible until March 26, 2026, with a specific passcode. Definitive Healthcare specializes in healthcare market data and analytics, helping organizations navigate the complexities of the healthcare industry to make informed decisions.
Potential Positives
- Definitive Healthcare will report its financial results for Q4 and full year 2025, indicating a commitment to transparency and accountability to investors.
- The company is hosting a conference call and webcast for investors, allowing for direct engagement and discussion of financial performance.
- The provision of a live audio webcast and replay options enhances accessibility for stakeholders, demonstrating an emphasis on investor communication.
Potential Negatives
- Announcement of financial results is scheduled for a future date, indicating potential uncertainties about current performance and results.
FAQ
When will Definitive Healthcare announce its financial results?
Definitive Healthcare will announce its financial results on February 26, 2026, after market close.
How can I listen to the Definitive Healthcare earnings call?
You can listen to the earnings call via webcast on the Definitive Healthcare Investor Relations website or by dialing in.
What time is the Definitive Healthcare conference call?
The conference call will take place at 5:00 PM ET / 2:00 PM PT.
How long will the conference call replay be available?
The replay of the conference call will be available until March 26, 2026.
What is Definitive Healthcare's focus in the healthcare industry?
Definitive Healthcare focuses on providing data and analytics to improve decision-making in the healthcare market.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$DH Revenue
$DH had revenues of $60M in Q3 2025. This is a decrease of -4.23% from the same period in the prior year.
You can track DH financials on Quiver Quantitative's DH stock page.
$DH Hedge Fund Activity
We have seen 47 institutional investors add shares of $DH stock to their portfolio, and 78 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC removed 1,432,475 shares (-16.4%) from their portfolio in Q3 2025, for an estimated $5,815,848
- CORIENT PRIVATE WEALTH LLC added 450,017 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,827,069
- D. E. SHAW & CO., INC. added 394,860 shares (+28.0%) to their portfolio in Q3 2025, for an estimated $1,603,131
- BANK OF AMERICA CORP /DE/ removed 358,519 shares (-46.6%) from their portfolio in Q3 2025, for an estimated $1,455,587
- CITADEL ADVISORS LLC removed 333,091 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,352,349
- VANGUARD GROUP INC removed 244,703 shares (-8.8%) from their portfolio in Q4 2025, for an estimated $702,297
- CITIGROUP INC added 159,179 shares (+122.5%) to their portfolio in Q3 2025, for an estimated $646,266
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DH Analyst Ratings
Wall Street analysts have issued reports on $DH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 08/08/2025
To track analyst ratings and price targets for $DH, check out Quiver Quantitative's $DH forecast page.
$DH Price Targets
Multiple analysts have issued price targets for $DH recently. We have seen 3 analysts offer price targets for $DH in the last 6 months, with a median target of $4.0.
Here are some recent targets:
- Saket Kalia from Barclays set a target price of $2.75 on 12/09/2025
- David Hynes from Canaccord Genuity set a target price of $4.0 on 11/10/2025
- David Grossman from Stifel set a target price of $6.0 on 08/08/2025
Full Release
FRAMINGHAM, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.
A live audio webcast of the event will be available on the Definitive Healthcare’s Investor Relations website at https://ir.definitivehc.com/ .
A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortly after the conclusion of the call, a replay of this conference call will be available through March 26, 2026 at 800-645-7964 or 757-849-6722. The replay passcode is 1765#.
About Definitive Healthcare
Definitive Healthcare is a data and analytics company focused on the business side of healthcare. The healthcare market is complex — our data makes it clearer. We cut through the noise to deliver the insights that healthcare organizations and companies need to make smarter, faster, more strategic decisions. Because when our customers succeed, healthcare gets better for everyone. Learn more at
definitivehc.com
.
Media Contact:
Bethany Swackhamer
[email protected]
Investor Relations Contact:
Brian Denyeau
ICR for Definitive Healthcare
[email protected]
Source: Definitive Healthcare Corp.
